Astria Therapeutics Investor Relations Material
Latest events
Study Result
Astria Therapeutics
Corporate Presentation
12 Aug, 2025
Q2 2025
12 Aug, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Astria Therapeutics Inc
Access all reports
Astria Therapeutics Inc., formerly known as Catabasis Pharmaceuticals, Inc., is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics for rare and niche allergic and immunological diseases. The company's lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein. Astria Therapeutics is headquartered in Boston, Massachusetts, and its shares are listed on the Nasdaq.
Key slides for Astria Therapeutics Inc
Corporate Presentation
Astria Therapeutics Inc
Corporate Presentation
Astria Therapeutics Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
ATXS
Country
🇺🇸 United States